Literature DB >> 26830785

Fever of unknown origin (FUO) in a renal transplant recipient due to drug fever from sirolimus.

Sairah Sharif1,2, May W Kong1,2, James Drakakis1,2, Burke A Cunha3,4.   

Abstract

INTRODUCTION: A variety of medications may cause drug fever. Drug fevers may persist for days to weeks until diagnosis is considered. The diagnosis of drug fever is confirmed when there is resolution of fever within 3 days after the medication is discontinued. Only rarely do undiagnosed drug fevers persist for over 3 weeks to meet fever of unknown origin (FUO) criteria. FUOs due to drug fever are uncommon, and drug fevers due to immunosuppressive drugs are very rare. CASE REPORT: This is a case of a 58-year-old female renal transplant recipient who presented with FUO that remained undiagnosed for over 8 weeks. DISCUSSION: We believe this is the first reported case of an FUO due to drug fever from sirolimus in a renal transplant recipient.

Entities:  

Keywords:  Atypical lymphocytes; Drug fever; Elevated serum transaminases; Relative bradycardia

Mesh:

Substances:

Year:  2016        PMID: 26830785     DOI: 10.1007/s15010-016-0877-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  13 in total

Review 1.  Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2007-12       Impact factor: 5.982

Review 2.  Fever of unknown origin: clinical overview of classic and current concepts.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2007-12       Impact factor: 5.982

3.  Fever of unknown origin (FUO) due to efalizumab, an immunomodulating agent.

Authors:  F M Pherez; B A Cunha
Journal:  J Chemother       Date:  2008-06       Impact factor: 1.714

4.  Drug fever. The importance of recognition.

Authors:  B A Cunha
Journal:  Postgrad Med       Date:  1986-10       Impact factor: 3.840

Review 5.  Drug fever: mechanisms, maxims and misconceptions.

Authors:  P A Mackowiak
Journal:  Am J Med Sci       Date:  1987-10       Impact factor: 2.378

Review 6.  Use of sirolimus in solid organ transplantation.

Authors:  Joshua J Augustine; Kenneth A Bodziak; Donald E Hricik
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state.

Authors:  Olivier Thaunat; Carole Beaumont; Lucienne Chatenoud; Sophie Lechaton; Marie-France Mamzer-Bruneel; Bruno Varet; Henri Kreis; Emmanuel Morelon
Journal:  Transplantation       Date:  2005-11-15       Impact factor: 4.939

8.  Clinically benign fever of unknown origin: a personal retrospective.

Authors:  L Weinstein
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

9.  Sirolimus-induced drug fever in a renal transplant patient: a case report.

Authors:  I Aires; D Carvalho; F Remédio; M Possante; A Ferreira; J R Pinto; F Nolasco; J R Santos
Journal:  Transplant Proc       Date:  2009-04       Impact factor: 1.066

10.  Fever of unknown origin in renal transplant patients with tacrolimus.

Authors:  Kathrin Hochegger; Michael Rudnicki; Martin Auinger; Walter Mark; Raimund Margreiter; Gert Mayer; Alexander R Rosenkranz
Journal:  Clin Transplant       Date:  2008-12-22       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.